Collegium Pharmaceutical Inc (COLL) — Cash Flow Quality Index
Collegium Pharmaceutical Inc (COLL) has a Cash Flow Quality Index of 2.49x as of September 2025. Operating cash flow of $78.44 Million exceeds net income of $31.51 Million, indicating high earnings quality where cash backs reported profits. Explore COLL debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Collegium Pharmaceutical Inc Cash Flow Quality Index (2020–2024)
Historical Cash Flow Quality Index for Collegium Pharmaceutical Inc across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see how efficiently does Collegium Pharmaceutical Inc generate cash.
Annual Cash Flow Quality Index for Collegium Pharmaceutical Inc (2020–2024)
Year-by-year earnings quality comparison for Collegium Pharmaceutical Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.96x | $204.98 Million | $69.19 Million | ▼ -48.1% |
| 2023 | 5.71x | $274.75 Million | $48.16 Million | ▲ +294.0% |
| 2021 | 1.45x | $103.56 Million | $71.52 Million | ▼ -58.8% |
| 2020 | 3.51x | $93.94 Million | $26.75 Million | — |